Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA6 | P23280 | 5/20 | 0.56 |
| ▸ | CA7 | P43166 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | CA4 | P22748 | 4/20 | 0.53 |
| ▸ | CA5A | P35218 | 4/20 | 0.53 |
| ▸ | CA3 | P07451 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5883453 | 1.00 | CA12 (0.56) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL4241285 | 1.00 | CA12 (0.56) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL17350397 | 0.97 | CA12 (0.58) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL6580110 | 0.97 | CA12 (0.53) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL2092025 | 0.97 | CA12 (0.53) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL7154083 | 0.97 | CA12 (0.53) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL3657736 | 0.97 | CA12 (0.59) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL863599 | 0.97 | CA12 (0.59) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL9716193 | 0.97 | CA12 (0.59) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL9100273 | 0.97 | CA12 (0.59) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118016944-A | Water system iron-cerium flow battery | 北京化工大学 | 2024-05-10 | — | — | CN | claimed |
| US-20180305297-A1 | DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2018-10-25 | — | — | US | claimed |
| CN-113301989-B | Water absorbing agent and method for producing water absorbing agent | 株式会社日本触媒 | 2024-06-14 | — | — | CN | disclosed |
| CN-118005961-A | Poly (meth) acrylic acid (salt) -based particulate water absorbing agent and method for producing same | 株式会社日本触媒 | 2024-05-10 | — | — | CN | disclosed |
| CN-118005960-A | Poly (meth) acrylic acid (salt) -based particulate water absorbing agent and method for producing same | 株式会社日本触媒 | 2024-05-10 | — | — | CN | disclosed |
| CN-113272365-B | Water absorbing agent containing water absorbing resin as main component and method for producing same | 株式会社日本触媒 | 2024-05-10 | — | — | CN | disclosed |
| CN-118016944-A | Water system iron-cerium flow battery | 北京化工大学 | 2024-05-10 | — | — | CN | disclosed |
| US-11931290-B2 | Water absorbent resin powder for heat-generating element composition, and heat-generating element composition | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-112119112-B | Method for producing water-absorbent resin | 株式会社日本触媒 | 2024-02-27 | — | — | CN | disclosed |
| CN-117257553-A | Water-absorbing sheet and absorbent article comprising same | 株式会社日本触媒 | 2023-12-22 | — | — | CN | disclosed |
| US-20230375472-A1 | PREDICTION METHOD AND PREDICTION DEVICE | NIPPON SHOKUBAI CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| CN-101919866-A | Drug composition of complex fat-soluble vitamins and preparation method thereof | SICHUAN KELUN PHARMACEUTICAL | 2010-12-22 | — | — | CN | disclosed |
| CN-101919831-A | Pharmaceutical composition compounded with compound liposoluble vitamins and preparation method thereof | SICHUAN KELUN PHARMACEUTICAL | 2010-12-22 | — | — | CN | disclosed |
| US-20100249320-A1 | Process for producing water-absorbing resin | NIPPON SHOKUBAI CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| CN-101129388-B | Pharmaceutical composition of composite fat-soluble vitamins and preparation method thereof | SICHUAN KELUN PHARMACEUTICAL | 2010-09-08 | — | — | CN | disclosed |
| CN-101821331-A | Water-absorbing resin composition and process for production of the same | NIPPON CATALYTIC CHEM IND | 2010-09-01 | — | — | CN | disclosed |
| EP-2189478-A1 | PROCESS FOR PRODUCING WATER-ABSORBING RESIN | Nippon Shokubai Co., Ltd. (JP) | 2010-05-26 | — | — | EP | disclosed |
| CN-101129388-A | Pharmaceutical composition of composite fat-soluble vitamins and preparation method thereof | SICHUAN KELUN PHARMACEUTICAL (CN) | 2008-02-27 | — | — | CN | disclosed |
| US-4273786-A | BY-PRODUCT INHIBITION WITH AN AMINOPOLYCARBOXYLIC ACID SALT | PERSONAL PRODUCTS COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| US-3935862-A | Inhibition of conditions arising from microbial production of ammonia | PERSONAL PRODUCTS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305297-A1 | DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | NAPEPLD, NAAA, DNPEP | CA12 146/4885CA6 92/4885CA7 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.